Medical News

RSS

SAMHSA to unveil results of 2009 National Survey on Drug Use and Health

The Substance Abuse and Mental Health Services Administration (SAMHSA) will unveil the results of the latest (2009) National Survey on Drug Use and Health (NSDUH) at a press conference on Thursday, September 16. The annual survey is the largest of its kind, and is the government's primary vehicle for determining how many persons are abusing illegal drugs, pharmaceuticals, alcohol and tobacco.

14 Sep 2010

AMCP supports legislation to prohibit financial agreements for delaying marketing of lower-cost generic drugs

The Academy of Managed Care Pharmacy (AMCP) supports the inclusion of legislative language similar to S. 369 — the Preserve Access to Affordable Generics Act — in appropriations legislation now under consideration by the Senate. S. 369 would prohibit financial agreements between brand-name and generic pharmaceutical manufacturers to delay the marketing of lower-cost generic drugs.

14 Sep 2010

Scientists study nanometer scale to develop artificial molecular machines

Molecular machines can be found everywhere in nature, for example, transporting proteins through cells and aiding metabolism. To develop artificial molecular machines, scientists need to understand the rules that govern mechanics at the molecular or nanometer scale (a nanometer is a billionth of a meter).

14 Sep 2010

Life cover reports 40% increase in sales for first half 2010

Life cover sales are up 40% to 63.5m pounds Sterling on an APE (Annual Premium Equivalent) basis, compared to 45.2m pounds in the first half of 2009. This includes retirement business seeing a 36% increase with an APE of 48.3 pounds (H1 2009: 35.4m pounds) while protection and savings businesses saw a 55% increase with an APE of 15.2m pounds (H1 2009: 9.8m pounds).

14 Sep 2010

Emergency physicians to present research studies at Research Forum 2010

The risks associated with boarding admitted patients in the emergency department – including patient mortality – as well as proposed solutions will be key themes of Scientific Assembly, the annual meeting of the American College of Emergency Physicians. In addition, emergency physicians will present more than 450 research studies during 2010 Research Forum, the premier, annual scientific research event focused on the latest advances in the practice of emergency medicine.

14 Sep 2010

Researchers demonstrate shape memory alloys in medical implants

A European team has demonstrated that modern technological materials used in a wide range of medical devices and implants are entirely biocompatible and should not health problems as has previously been suggested.

14 Sep 2010

Survey highlights safety concerns of patients crossing borders for infertility treatment

The European Society of Human Reproduction and Embryology (ESHRE) and the International Federation of Fertility Societies (IFFS) are concerned that the safety of patients crossing borders is no longer assured due to lack of uniform clinical and safety standards between the different countries. Additionally patients returning home often face legal and medical complications, as local health services take on the responsibility for treatment initiated abroad.

14 Sep 2010

Public reporting of individual physician quality data may help seekers of high-quality health care

Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

14 Sep 2010

Pernix completes Macoven acquisition

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced the acquisition of 100% of the outstanding membership interest in Macoven Pharmaceuticals, L.L.C. for approximately $2.2 million (which includes inventory of approximately $1.2 million), its entry into a $10 million credit facility with Regions Bank and the repurchase of 2,000,000 shares of its common stock from one of its employees in a privately negotiated transaction.

14 Sep 2010

Role of health centers in national health reform

A new issue brief from The Kaiser Family Foundation's Commission on Medicaid and the Uninsured, co-authored by Commission staff and researchers at the George Washington University's Geiger Gibson/RCHN Community Health Foundation Research Collaborative, examines the role of health centers in national health reform and the issues that will affect health center expansion to meet the growing need for primary health care.

14 Sep 2010

Success of assisted reproduction procedures linked to season

The success of an assisted reproduction procedure may depend on the season. This is the finding of new work presented at the World Congress of Fertility and Sterility, in Munich, Germany.

14 Sep 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

14 Sep 2010

RS Medical receives Federal Supply Schedule contract

International Rehabilitative Sciences, Inc. d/b/a RS Medical, announced today its first award of a Federal Supply Schedule contract. The contract is in effect through June 14, 2015.

14 Sep 2010

U.S. adults support restrictions on e-cigarettes based on potential risks

According to the makers of electronic cigarettes, they are new devices that allow users to inhale nicotine but not the toxins of tobacco cigarettes. Advocates hail e-cigarettes as a possible quit-smoking aid.

14 Sep 2010

Convergent Procedure for AF highlighted at EACTS 2010

The Convergent Procedure, a novel approach to treat atrial fibrillation (AF), enabled by epicardial ablation products from nContact Surgical, Inc., was highlighted at the Techno-College Atrial Fibrillation Session of the EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting in Geneva, Switzerland. More than 1,000 medical professionals attended the 2010 Techno-College Programme to receive an update on the latest technical advancements in cardiothoracic surgery.

14 Sep 2010

Gladstone Institute elects for 2010 recipient of Avant-Garde Award for HIV/AIDS Research

The National Institute on Drug Abuse, part of the National Institutes of Health, announced today that Dr. Eric M. Verdin of the J. David Gladstone Institutes in San Francisco, Calif., has been selected as the 2010 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research for his proposal to study the mechanisms of latent HIV infection.

14 Sep 2010

NICE clinical guideline for bacterial meningitis and meningococcal septicaemia in children

Every parent knows the story and every parent dreads it. You take a feverish child to the doctors, you know something isn't right; but you are just sent back home with advice about paracetamol. Hours later the child is admitted to hospital with meningitis.

14 Sep 2010

New York Hospital Queens opens new 190,000 square feet 'West Wing'

New York Hospital Queens invites the news media to tour its newly opened West Wing. The opening of the new building marks a major milestone for the hospital, for physicians and patients in Queens. The new seven-floor building, known as the "West Wing," has 190,000 square feet, and adds 80 certified patient beds, bringing the hospital's total to 519.

14 Sep 2010

Progenics Pharmaceuticals presents findings of humanized monoclonal antibodies against C. difficile bacterium

Progenics Pharmaceuticals, Inc. today presented preclinical findings for its humanized monoclonal antibodies against the disease-causing toxins produced by the bacterium Clostridium difficile.

14 Sep 2010

Icagen suspends further enrollment in ICA-105665 study

Icagen, Inc. today announced that due to the occurrence of a serious adverse event in the photosensitivity study of ICA-105665, the Company has suspended further enrollment in the study. The serious adverse event occurred in the 600mg patient cohort following completion of the 500mg patient cohort.

14 Sep 2010

Medical News

SAMHSA to unveil results of 2009 National Survey on Drug Use and Health

AMCP supports legislation to prohibit financial agreements for delaying marketing of lower-cost generic drugs

Scientists study nanometer scale to develop artificial molecular machines

Life cover reports 40% increase in sales for first half 2010

Emergency physicians to present research studies at Research Forum 2010

Researchers demonstrate shape memory alloys in medical implants

Survey highlights safety concerns of patients crossing borders for infertility treatment

Public reporting of individual physician quality data may help seekers of high-quality health care

Pernix completes Macoven acquisition

Role of health centers in national health reform

Success of assisted reproduction procedures linked to season

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

RS Medical receives Federal Supply Schedule contract

U.S. adults support restrictions on e-cigarettes based on potential risks

Convergent Procedure for AF highlighted at EACTS 2010

Gladstone Institute elects for 2010 recipient of Avant-Garde Award for HIV/AIDS Research

NICE clinical guideline for bacterial meningitis and meningococcal septicaemia in children

New York Hospital Queens opens new 190,000 square feet 'West Wing'

Progenics Pharmaceuticals presents findings of humanized monoclonal antibodies against C. difficile bacterium

Icagen suspends further enrollment in ICA-105665 study

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News